SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Thursday reported a loss of $44.6 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 17 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.
The biotechnology firm posted revenue of $34,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
